GUSE Goldman Sachs Enhanced U.S. Equity ETF

Expense Ratio
0.3%
Dividend
0.75%
Previous close
$39.38
Est. 12 months change
+22.36%
Projected Price
$48.19

Profitability Metrics

Return on Equity (ROE)
47.11%
Return on Assets (ROA)
13.90%
Return on Invested Capital (ROIC)
38.11%
Weighted Average Cost of Capital (WACC)
9.64%
ROIC - WACC
28.47%
Updated : 2026-04-04 08:29 ET

Valuation Metrics

P/E Ratio
27.27
Forward P/E
21.33
PEG Ratio
2.17
Debt Current Ratio
1.74

Growth & Cash Flow

Gross Margin
54.39%
Operating Margin
29.65%
FCF Margin
21.51%
TTM Revenue Growth
19.87%
Projected 12M EPS Growth
27.86%

Price Change

Price % from 50 SMA
-2.65%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
NVDA7.73%
AAPL6.13%
MSFT5.00%
AMZN3.99%
GOOGL3.35%
AVGO2.65%
META2.55%
GOOG2.26%
TSLA1.99%
JNJ1.85%

ETF Analysis

Fund Overview

Goldman Sachs Enhanced U.S. Equity ETF (GUSE) currently reports 119 stock positions (subject to change), placing it in the highly diversified range by holdings breadth. The top line-up is NVDA (7.73%), AAPL (6.13%), MSFT (5.00%), with NVDA as the largest single weight at 7.73%. Together, the top three holdings account for 18.86%, which implies a more democratized weight structure where the broader holding set matters as much as the leadership group. This structure gives the portfolio a dual character: meaningful exposure to its highest-conviction names, alongside enough breadth to dampen idiosyncratic noise.

Profitability & Capital Efficiency

Examining the portfolio through a capital allocation lens, ROIC is 38.11%, WACC is 9.64%, and the economic spread is 28.47%. On balance, the economic spread here is exceptional — few portfolios sustain this kind of gap between operating returns and cost of capital. Supporting metrics show ROE at 47.11% and ROA at 13.90%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

Multiple analysis puts the portfolio at trailing P/E of 27.27, forward P/E of 21.33, PEG of 2.17. Trailing P/E sits modestly above forward P/E, a spread that is consistent with steady earnings progress and limited near-term re-rating potential. On a PEG basis, valuation is in the middle ground — fair for the growth on offer, with the return case resting on earnings delivery rather than re-rating. The aggregate current ratio of 1.74 reflects a holding set with workable near-term liquidity positions. The combined valuation and liquidity profile points to a portfolio where current prices embed meaningful growth expectations, and where delivery against those expectations will drive the return outcome.

Margins & Cash Generation

From gross to free cash flow, gross margin sits at 54.39%, operating margin at 29.65%, and free cash flow margin at 21.51%. At this gross margin level, the holdings demonstrate adequate production efficiency without commanding premium pricing. The operating margin reading is healthy — adequate to support reinvestment without sacrificing profitability. The portfolio's FCF margin is above average, pointing to holdings with efficient capital deployment and durable cash generation. Taken together, the margin profile reflects a collection of businesses with genuine competitive advantages — capable of sustaining profitability and generating cash across a range of economic conditions.

Growth & Forward Outlook

Combining revenue momentum with analyst targets, the estimated 12-month price change of 22.59%, where consensus expectations favor gradual appreciation over the next year, while TTM revenue growth of 19.87% reflecting moderate but reliable revenue progress across the basket. Separating operating reality from market-implied expectations is useful here — they can diverge meaningfully when sentiment shifts. The forward return case hinges on whether the operating reality stays close enough to analyst assumptions for those targets to remain credible. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

When all the evidence is placed side by side, this profile stands out as one with genuine compounding characteristics and limited structural headwinds.

The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.